Number 32

Talking the same language

Editorial 1 September 2009 0

  Download full article

... [ more ]

Eric Van Cutsem: closing in on GI tumours

Cover Story 1 September 2009 0

Eric Van Cutsem has been at the forefront of developing new molecular therapies for gastrointestinal cancers, but he’s not relying on finding that magic bullet. He advocates a many-fronted attack, combining genetic counselling with screening [more]

... [ more ]

State-of-the-art and controversies in germ-cell cancer

Grandround 1 September 2009 0

Many different, intersecting strategies are available for managing germ-cell cancers, particularly in early-stage disease. Which is ‘right’ remains a matter of debate, and requires balancing efficacy against late effects, bearing in mind the complexity of [more]

... [ more ]

Gotta get that rhythm – Circadian timing systems and cancer

Spotlight on 1 September 2009 0

The role of circadian rhythms in cancer hit the headlines this year because of growing evidence that night shift work may increase the risk of breast cancer. But could a better understanding of the role [more]

... [ more ]

Are we educating women to be afraid? UK health reporter questions the value of simplistic screening messages

Spotlight on 1 September 2009 0

Breast screening programmes won’t work if women don’t attend. But can this justify campaigns that exaggerate both the risk of getting breast cancer and the benefits of screening? Margaret McCartney believes not. She won a [more]

... [ more ]

Vested interests are undermining our efforts to beat cancer – The worries of a battle-hardened German oncologist

Spotlight on 1 September 2009 0

Cancer treatment is at a critical juncture, says Dieter K Hossfeld, veteran campaigner for the recognition of medical oncology in Germany. Future progress, he believes, depends on reasserting the interests of society at large over [more]

... [ more ]

Effect of treatment interruptions in prostate cancer

Impact Factor 1 September 2009 0

A recent study has shown that treatment interruptions during a fractionated external-beam radiotherapy course for localised prostate cancers may have a negative effect on patient outcome. Limiting or modifying the overall elapsed time between treatments [more]

... [ more ]

Endocrine-therapy-related symptoms and breast cancer

Impact Factor 1 September 2009 0

The association of a treatment-related adverse effect with treatment success has been reported in various clinical situations. The development of vasomotor or joint symptoms is an indication of therapeutic benefit in women receiving endocrine treatment [more]

... [ more ]

Newsround

Senza categoria 1 September 2009 0

Selected reports edited by Janet Fricker Download full article

... [ more ]

A man with a woman’s cancer How can we do better for male breast cancer patients?

Patient Voice 1 September 2009 0

Being diagnosed with a “woman’s” cancer can pose all sorts of problems for a man. Should breast cancer advocacy groups be more welcoming? Do men need their own groups, or don’t they do that sort [more]

... [ more ]